Successful treatment of steroid-dependent gastrointestinal acute graft-versus-host disease with mesenchymal stromal cells administered more than 100 days after allo-HCT

Administration of mesenchymal stromal cells (MSCs) represents a promising therapy for steroid-resistant acute graft-versus-host disease (aGVHD). However, its efficacy in pediatric patients with steroid-dependent aGVHD remains unclear, given the paucity of studies performed in children. In addition,...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsushima, Satoru, Kobayashi, Ryoji, Hori, Daiki, Yanagi, Masato, Kodama, Koya, Sano, Hirozumi, Suzuki, Daisuke, Kobayashi, Kunihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847261/
https://www.ncbi.nlm.nih.gov/pubmed/36714266
http://dx.doi.org/10.31547/bct-2021-013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847261/
https://www.ncbi.nlm.nih.gov/pubmed/36714266
http://dx.doi.org/10.31547/bct-2021-013

Ejemplares similares